Treatments and Guidelines

pronounced as 'pred' ni sone'

https://healthify.nz/medicines-a-z/p/prednisone/

pronounced as 'sye kloe foss' fa mide'

https://healthify.nz/medicines-a-z/c/cyclophosphamide/

pronounced as 'rye-TUX-ih-mab'

https://healthify.nz/medicines-a-z/r/rituximab/

https://schedule.pharmac.govt.nz/2025/05/01/SA2233.pdf

See page 2 for ANCA Vasculitis

In July 2024 an application was made to Pharmac to fund Rituximab for maintenance therapy of ANCA vasculitis. See

https://connect.pharmac.govt.nz/apptracker/s/application-public/a10OZ000001ye3d/p002077 

pronounced as  'ME-poe-LIZ-ue-mab'

https://healthify.nz/medicines-a-z/m/mepolizumab/

https://schedule.pharmac.govt.nz/2025/05/01/SA2331.pdf

See page 2 for eosinophilic granulomatosis with polyangiitis ANCA Vasculitis

pronounced as 'ay-za-THYE-oh-preen'

https://healthify.nz/medicines-a-z/a/azathioprine/

pronounced as 'meth-o-trex-ate'

https://healthify.nz/medicines-a-z/m/methotrexate/

https://rheumatology.org/vasculitis-guideline

https://ard.bmj.com/content/early/2023/03/16/ard-2022-223764

Avacopan 

Our society is currently lobbying to get this new promising treatment into New Zealand. Currently the Rare Disorders Society is speaking to Pharmac to see if they will communicate with CSL to make an application to medsafe

https://ancavasculitisnews.com/tavneos-avacopan-ccx168

In April 2024 an application was made to Pharmac to fund Avacopan for ANCA vasculitis. See

https://connect.pharmac.govt.nz/apptracker/s/application-public/a10OZ000001CBGs/p002050